Magazine 14.17

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First ItalianζoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.

Date: 2021

Scope of interest: Epilepsy

You may also be interested in:

Magazine 6.52

Aripiprazole-Triggered Alice in Wonderland Syndrome Episodes Studied with 99mTc-HMPAO brain SPECT.

Authors: Mancini V, Mastria G, Frantellizzi V, Viganò A, Petsas N, Sollaku S, Fanella M, Di Bonaventura C, Liberatore M, Di Piero V

Date: 2018

Scope of interest: Headache

Read details

Report/Poster of Convention/Congress Act

Outpatient Management of Secondary Epistaxis Anemia in Patients with Rendu-Osler Disease: The Role of Intravenous Martial Therapy

Authors: Trimboli M. et. al. D’Amico C. et al.

Date: 2022

Scope of interest: Transfusion Medicine

Read details

Magazine 18.31

An Italian multicentre study of perampanel in progressive myoclonus epilepsies.

Authors: Canafoglia L, Barbella G, Ferlazzo E, Striano P, Magaudda A, d 'Orsi G, Martino T, Avolio C, Aguglia U, Sueri C, Giuliano L, Sofia V, Zibordi F, Ragona F, Freri E, Costa C, Nardi Cesarini E, Fanella M, Rossi Sebastiano D, Riguzzi P, Gambardella A, Di Bonaventura C, Michelucci R, Granata T, Bisulli F, Licchetta L, Tinuper P, Beccaria F, Visani E, Franceschetti S

Date: 2019

Scope of interest: Epilepsy

Read details